Investing.com - Fortress Biotech (NASDAQ: FBIO) reported third quarter EPS of $-0.9400, $0.72 worse than the analyst estimate of $-0.2200. Revenue for the quarter came in at $34.75M versus the consensus estimate of $14.28M.
Fortress Biotech's stock price closed at $1.3200. It is down -79.7800% in the last 3 months and down -90.0000% in the last 12 months.
Fortress Biotech saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Fortress Biotech's stock price’s past reactions to earnings here.
According to InvestingPro, Fortress Biotech's Financial Health score is "weak performance".
Check out Fortress Biotech's recent earnings performance, and Fortress Biotech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar